The Botulinum Toxin Innovation: From Powder to Liquid.

[BACKGROUND] Botulinum toxin (BoNT) has evolved as a popular treatment for various medical and aesthetic conditions since the 1980s. The emergence of new liquid formulation BoNT products in the industry highlights the need to evaluate the value and advantages of these modern formulations.

[OBJECTIVE] The aim of this review was to assess and compare the expected difference in practice between liquid and powder formulation BoNT products.

[PAITENTS AND METHODS/MATERIALS] This article involves a review of pertinent guidelines, product information from manufacturers, available database for safety reports, and survey results.

[RESULTS] Guidelines and safety reports have pointed out potential risks in the reconstitution process, while medication preparation steps are simplified in liquid formulation.

[CONCLUSION] The shift toward ready-to-use liquid products can mitigate risks related with reconstitution errors and potentially enhancing patient care by saving time and cost associated with medication preparation.